Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Europe does it better: molecular testing across a national health care system-the French example.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting - 1 Jan 2013

Nowak Frédérique, Calvo Fabien, Soria Jean-Charles

Abstract excerpt

Drug approvals for molecularly stratified tumor subgroups make molecular testing mandatory and require that molecular diagnostics be performed nationwide. To this end, the French National Cancer Institute (INCa) and the French Ministry of Health have set up a national network of 28 regional molec...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Delivery of Health Care
Share to France

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Health Services Accessibility

Share to Molecular Targeted Therapy

Share to Mutation

Share to Neoplasms

Source

Identifiers

PMID: 23714540
DOI: 10.14694/EdBook_AM.2013.33.332

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23714540-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Europe does it better: molecular testing across a national health care system-the French example.PMID 23714540Read ↗

Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in BelgiumSemantic proximity Read ↗

Cancer genetics services in Europe.Semantic proximity Read ↗

Unlocking precision oncology by establishing a nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer: the BALLETT studySemantic proximity Read ↗

Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers' survey.Semantic proximity Read ↗

DNA diagnosis and the emergence of cancer genetic services in European health care.Semantic proximity Read ↗

Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk SyndromesSemantic proximity Read ↗

Bringing onco-innovation to Europe’s healthcare systems: the unexploited potential of biomarker testing, real world evidence and the potential of Tumour Agnostics. The lesson from BRCA1/2 genetic testingSemantic proximity Read ↗

Improving public cancer care by implementing precision medicine in Norway - IMPRESS-NorwaySemantic proximity Read ↗

The changing landscape of genetic testing and its impact on clinical and laboratory services and research in EuropeSemantic proximity Read ↗

Importance of EQA/PT for the detection of genetic variants in comprehensive cancer genome testingSemantic proximity Read ↗

Overview of Molecular Diagnostics in Irish Clinical OncologySemantic proximity Read ↗

Overview of Molecular Diagnostics in Irish Clinical OncologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.